VahatiCor CEO Harry Rowland explains how the nitinol A-Flux reducer implant is designed to treat coronary microvascular ...

Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

A genome-wide association study links genetic variants to reduced coronary flow reserve, implicating the nuclear factor kappa B pathway in coronary microvascular disease.

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at University of Michigan, according to a recent study. Researchers trained the ...

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...

ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 ...

A study carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid, Spain provides crucial information about the effect of cardiometabolic risk factors and subclinical ...

Dr. Ashesh Buch, an interventional cardiologist at Chesapeake Regional Medical Center, led the development of introducing a coronary microvascular dysfunction testing program to the region. Chesapeake ...